Quilter PLC Leap Therapeutics, Inc. Transaction History

Quilter PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.08 - $3.65 $145,600 - $255,500	-70,000 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$1.35 - $4.01 $94,500 - $280,700	70,000 New	70,000 $281,000
Q2 2020 Aug 12, 2020	SELL	$1.39 - $2.84 $69,500 - $142,000	-50,000 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$0.63 - $1.37 $31,500 - $68,500	50,000 New	50,000 $56,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $275M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Quilter PLC, based on Form 13F filings with the SEC.

Stay updated on Quilter PLC with notifications on news.